A novel targeted delivery system for drug-resistant hepatocellular carcinoma therapy-Reference-Cited by-同舟云学术

A novel targeted delivery system for drug-resistant hepatocellular carcinoma therapy

Author:

Xiao Li¹²³⁴⁵,Hou Yang⁶⁷⁸⁹,He Huimin¹²³⁴⁵,Cheng Sinan¹²³⁴⁵,Hou Yifan¹²³⁴⁵,Jin Huijuan¹²³⁴⁵,Song Xigui¹²³⁴⁵,Nie Guochao¹⁰¹¹⁹,Hou Yingchun¹²³⁴⁵^ORCID

Affiliation:

1. National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China

2. The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry

3. The Ministry of Education

4. College of Life Sciences

5. Shaanxi Normal University

6. Department of Orthopedic Surgery

7. Changzheng Hospital

8. Shanghai 200003

9. China

10. Guangxi Key Laboratory of Agricultural Resource Chemistry and Biotechnology

11. Yulin

Abstract

HCSP4-Lipo-DOX-miR101 is a novel and efficient approach for HCC targeted therapy with MDR inhibition in vitro and in vivo.

Funder

National Natural Science Foundation of China

Scientific Research and Technology Development Program of Guangxi

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

Reference46 articles.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献